Abrocitinib Highly Effective as Long-term Monotherapy in AD Abrocitinib Highly Effective as Long-term Monotherapy in AD

The head-turning outcomes achieved at the higher studied dose of 200 mg once daily as monotherapy herald a new era in the management of atopic dermatitis.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Dermatology News Source Type: news